-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Alnylam Pharmaceuticals, Raises Price Target to $395

Benzinga·08/01/2025 14:23:23
Listen to the news
Wells Fargo analyst Tiago Fauth maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Equal-Weight and raises the price target from $333 to $395.